| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.6 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |